U.S., April 8 -- ClinicalTrials.gov registry received information related to the study (NCT07515079) titled 'Efficacy Evaluation Study of BAT5906 and Lucentis(R) in Patients With Diabetic Macular Edema' on March 23.
Brief Summary: A multicenter, randomized, double-blind, parallel-group, active-controlled non-inferiority trial. A total of 406 subjects with diabetic macular edema (DME) were planned for enrollment. After screening, eligible subjects were randomized in a 1:1 ratio to the treatment group or the control group. The treatment group received BAT5906 injection, while the control group received Lucentis(R). During the trial, ophthalmic examinations and safety assessments were conducted according to the protocol for efficacy and safet...